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Abstract
Introduction Linkage and retention in HIV medical
care remains problematic in the USA. Extensive health
utilisation data collection through electronic health records
(EHR) and claims data represent new opportunities for
scientific discovery. Big data science (BDS) is a powerful
tool for investigating HIV care utilisation patterns. The
South Carolina (SC) office of Revenue and Fiscal Affairs
(RFA) data warehouse captures individual-level longitudinal
health utilisation data for persons living with HIV (PLWH).
The data warehouse includes EHR, claims and data from
private institutions, housing, prisons, mental health,
Medicare, Medicaid, State Health Plan and the department
of health and human services. The purpose of this study
is to describe the process for creating a comprehensive
database of all SC PLWH, and plans for using BDS to
explore, identify, characterise and explain new predictors
of missed opportunities for HIV medical care utilisation.
Methods and analysis This project will create personlevel profiles guided by the Gelberg-Andersen Behavioral
Model and describe new patterns of HIV care utilisation.
The population for the comprehensive database comes
from statewide HIV surveillance data (2005–2016) for
all SC PLWH (N≈18000). Surveillance data are available
from the state health department’s enhanced HIV/AIDS
Reporting System (e-HARS). Additional data pulls for
the e-HARS population will include Ryan White HIV/AIDS
Program Service Reports, Health Sciences SC data and
Area Health Resource Files. These data will be linked to
the RFA data and serve as sources for traditional and
vulnerable domain Gelberg-Anderson Behavioral Model
variables. The project will use BDS techniques such
as machine learning to identify new predictors of HIV
care utilisation behaviour among PLWH, and ‘missed
opportunities’ for re-engaging them back into care.
Ethics and dissemination The study team applied for
data from different sources and submitted individual
Institutional Review Board (IRB) applications to the
University of South Carolina (USC) IRB and other local
authorities/agencies/state departments. This study was
approved by the USC IRB (#Pro00068124) in 2017. To
protect the identity of the persons living with HIV (PLWH),
researchers will only receive linked deidentified data
from the RFA. Study findings will be disseminated at local
community forums, community advisory group meetings,
meetings with our state agencies, local partners and
other key stakeholders (including PLWH, policy-makers
and healthcare providers), presentations at academic

Strengths and limitations of this study
►► This study is among the first in the USA to accu-

mulate individual level data from multiple sources
for predictive model development and validation of
health utilisation in a statewide population of persons living with HIV (PLWH).
►► This study is unique in its ability to examine health
utilisation for all South Carolina PLWH from initial diagnosis across different treatment points and times
in the HIV treatment cascade.
►► Obtaining data release agreement, collecting and
merging HIV sensitive data from different entities
require significant time and effort to ensure privacy
and confidentiality of all subjects.
►► Although missing data or incorrect data may be a
problem for care status classification, mandatory
statewide reporting of HIV diagnosis and laboratory
markers (CD4 and viral load) provides confidence in
data completeness.
►► Machine learning techniques could yield a several
combinations of factors that could be difficult to interpret, but in anticipation of this problem, we have
constituted a clinician expert review panel, and plan
to use chart abstractions for further validation.
conferences and through publication in peer-reviewed
articles. Data security and patient confidentiality are
the bedrock of this study. Extensive data agreements
ensuring data security and patient confidentiality for the
deidentified linked data have been established and are
stringently adhered to. The RFA is authorised to collect and
merge data from these different sources and to ensure
the privacy of all PLWH. The legislatively mandated SC
data oversight council reviewed the proposed process
stringently before approving it. Researchers will get only
the encrypted deidentified dataset to prevent any breach
of privacy in the data transfer, management and analysis
processes. In addition, established secure data governance
rules, data encryption and encrypted predictive techniques
will be deployed. In addition to the data anonymisation as
a part of privacy-preserving analytics, encryption schemes
that protect running prediction algorithms on encrypted
data will also be deployed. Best practices and lessons
learnt about the complex processes involved in negotiating
and navigating multiple data sharing agreements between
different entities are being documented for dissemination.
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1. Use five commonly used measures of retention (described elsewhere) in HIV care25 to generate a profile
and pattern of care-seeking behaviour for SC PLWHs.
2. Use data mining and predictive analytics to identify
missed opportunities for HIV testing prior to HIV diagnoses for SC PLWHs using CD4 count/VL as laboratory-based markers of time.
3. Identify gaps in the treatment cascade for all SC PLWHs
who were never in care, not in care or who transition
in and out of care compared with those consistently in
HIV medical care.
4. Develop and validate a predictive risk model useful
for targeting HIV care linkage interventions to all SC
PLWHs who are never in care, not in care, transition
in and out of care and at risk for dropping out of care.
Purpose
The purpose of this study is to describe the framework
and process for creating a comprehensive database of all
SC PLWH and plans for using BDS to explore, identify,
characterise and explain new predictors of missed opportunities for HIV medical care utilisation. Study findings
will be integrated with ongoing efforts of the SC DHEC’s
Data-to-Care (DTC) Program, and the Ryan White Care
Program to link and retain PLWH in care.

Methods and analysis
This project is a population cohort-based study aimed at
improving HIV treatment for all SC PLWH. Analytic focus
will be on classification to predict where missed opportunities occur, gap identification and utilisation management across the HIV treatment cascade. We will classify
the PLWH to four care groups: (1) never in care, (2) transitioning in and out of care, (3) not in care and (4) consistently in care using CD4/VL laboratory biomarkers and
other demographics. An investigation into why certain
health utilisation behaviours occur within the care group
will be done using segmentation analysis. We will use
predictive data mining to score newly identified variables
representing the probability of the individual behaviour
(action) occurring in the future (in this case HIV medical
care utilisation).26–28 Findings will be validated through
a triangulated process involving the use of a HIV clinician expert panel, chart abstraction review process and
through the ‘DTC’ community advisory board to explain
and interpret new patterns/characteristics.
Guiding conceptual framework
This study is informed by an adaptation of the Gelberg-Andersen Behavioral Model framework.11 26 This model
identifies factors affecting health services utilisation
among vulnerable patient populations and measures
domains relevant for elucidating health utilisation
patterns.29 30 Socioecological factors affecting engagement in HIV medical care model will help guide the interpretation of new clusters of predictors.12 Studies have
Olatosi B, et al. BMJ Open 2019;9:e027688. doi:10.1136/bmjopen-2018-027688
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Introduction
Ending the HIV epidemic requires focus on ‘treatment
as prevention’ as a goal. Prevention through linkage
and retention in HIV medical care are key objectives of
Healthy People 2020 and National HIV/AIDS Strategy.1 2
Advances in HIV medications have made living a healthy
life possible for persons living with HIV (PLWH), with
well-established associations between linkage to/retention
in HIV medical care and viral load (VL) suppression.3–17
Recent numbers and proportions of South Carolina (SC)
PLWH engaged in each step of the HIV treatment cascade
show that cumulatively, only 66% received any medical
care, and of these, only 54% received continuous HIV
medical care.18 Similarly, national estimates show that
42%–59% of patients with HIV are not in HIV medical
care.4 12 19
Health inequities persist in the HIV treatment cascade
for PLWH in SC.20 These health inequities are important
since a lack of engagement and retention in HIV medical
care increases the likelihood of HIV transmission due
to poor VL suppression.3–14 16 17 Neither access to health
insurance nor early linkage to care have thus far predicted
retention in and consistent use of HIV medical care. This
study proposes using both statistical and machine learning
techniques to identify new and important predictors of
HIV cascade treatment outcomes for PLWH, that is, CD4
and VL.
A responsive healthcare system must engage all PLWH
at all stages of the HIV treatment cascade from HIV
testing, linkage to care, timely initiation of care, retention
in care and adherence to antiretroviral treatment (ART)
with repeated CD4/viral load (VL) testing. Adoption of
electronic health records (EHR), combined with the use
of big data science (BDS) techniques provides an opportunity to improve health outcomes and manage high-risk
and high-cost PLWH.21–24 This study will create a comprehensive dataset accumulated from multiple sources, and
use innovative BDS techniques to analyse new and old
predictors of retention in HIV medical care. General
health utilisation behaviour pre-HIV diagnosis will be
studied to identify where missed opportunities for HIV
testing occurs. PLWH profiles based on HIV medical care
seeking behaviour will be developed with concomitant
identification of gaps in HIV care and missed opportunities. The resulting model from this study will be used
by the State Department of Health and Environmental
Control (DHEC) to improve HIV care, through individual targeted linkage to, and retention in care. This
study extends beyond the traditional scope of most HIV
research in proposing novel machine learning processes
for developing and validating a model of HIV medical
care utilisation. In this protocol, we describe the process
for acquiring datasets, data linkages and methods we will
use to establish a population cohort from 2005 to 2016.
Linkage of different datasets at the individual level using
unique identifiers (IDs) at the population level enables us
to achieve the following specific aims:

Open access

Study area and population
This study will be conducted in SC located in the southeastern region of the USA, with a population of 4 961 119
in 2016.37 Current epidemiological profile shows the
PLWH ((n=18998) as mostly African-American [69%],
men (71%) and aged 30–49 years (41%)).38
Data sources
The proposed data linkage is complex, and the comprehensive dataset is large. To our knowledge, no such data
have ever been linked to study HIV treatment outcomes
at the population level in the USA. Novel application of
BDS techniques using a population of PLWHs can break
new grounds and provide additional tools for improving
care outcomes through the estimation of individual risks.
Data sources are described in greater detail below.
SC Office of Revenue and Fiscal Affairs (RFA) Integrated Data
System
RFA collects individual health utilisation data based
on state laws requiring mandatory data reporting. The
state law Section 44-6-170 guides the RFA in collecting
and releasing healthcare related data. Since 1996, the
RFA receives reports on all diagnoses from emergency
departments, hospital inpatient, ambulatory care and
outpatient surgery facilities in the Uniform Billing form
(UB-92) format.39 Non-compliant facilities face stiff penalties which increases compliance. At the RFA, individual
patient information will be linked using unique patient
IDs such as name, birth date and social security number.

Figure 1

The RFA’s integrated data structure is recognised as a
great example of an integrated data system in the USA
(figure 1).40 Data from RFA includes, but are not limited
to:
1. All payer healthcare inpatient database.
2. Medicaid services claims data (including demographic
file, visits file and pharmacy file).
3. State Employee Health Services Plan data.
4. Department of Corrections data (crime rates, prison
history, etc).
5. Department of Mental Health.
DHEC e-HARS and Ryan White RSR data
Confidential name-based reporting of HIV/AIDS in SC
as a reportable disease began in February 1986 leading to
the creation of DHEC’s enhanced HIV/AIDS reporting
system (e-HARS).39 41 e-HARS is a laboratory-based
reporting system to which all statewide CD4 and VL tests
are reported since 1 January 2004 as mandated by the
Code of Laws of SC Section 44-29-10: Regulation 61-20.39 41
e-HARS is a collection of computer programs and data
files developed by the Centers for Disease Control and
Prevention to simplify the management and analysis of
HIV/AIDS surveillance data. DHEC also provides linkage
to Ryan White Care clinic data through the Ryan White
HIV/AIDS Program Service Reports (RSR). The annual
RSR captures information regarding the services provided
by all Ryan White-funded entities.42
Health Sciences South Carolina (HSSC) Data
HSSC is a biomedical research collaborative consisting
of six of the state’s largest health systems namely the

South Carolina Office of Revenue and Fiscal Affairs Integrated Data System.
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identified factors referred to in both models as important
to PLWH.18 19 31–36
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Area Health Resources File (AHRF) and census tract data
The AHRF is a public dataset made available by Health
Resources and Services Administration which contains
data on healthcare professions, hospitals and healthcare facilities and US census population data. The AHRF
provides health system-level information in areas such as
healthcare professions, health facilities, hospital utilisation, expenditure and environment. Additional data on
education, poverty, median income, employment, and so
on, for different areas in SC will be extracted from the
American Community Survey data.
Data linkage, release and security
RFA operations are guided by the SC data oversight council
(DOC) as mandated by the state legislative assembly. The
DOC oversees and regulates the collection and release of
healthcare data in approved formats based on prevailing
privacy laws. Data elements, which, when linked to other
databases, can directly or indirectly identify a patient/
healthcare professional, health insurer or healthcare
facility are restricted. Protected health information such
as patient name, address and social security numbers
are never releasable; however, the RFA will use them to
conduct final data linkages. The RFA will act as the honest
data broker, deidentify the data and create unique IDs
useful for research purposes. Table 1 demonstrates the
extent of data linkage and highlights connections across
different data sources. Detailed data release agreements
are required and were secured from each data source
before linkage. As a result of the scope and complexity
of the data linkage, the state health department (DHEC)
and the RFA created an intra-agency data sharing agreement to guide the data sharing process between both
agencies. This intra-agency agreement provided specific
terms and rules for data linkage to ensure confidentiality. In addition, SC Medicaid, departments of mental
health, social services and corrections carefully reviewed
the proposed data linkage to ensure stringent adherence
to patient confidentiality. During data linkage, the RFA
retained the right to create new variables in lieu of variables that could remotely identify any individual. Two
examples are described here. First, the RFA scrambled
the dates by introducing a modifier known only to them,
while maintaining the original time between each date.
This made it impossible for researchers to identify PLWH
based on dates of service. In another example, rather than
releasing spatial identifying data like zip codes or census
4

block information, the RFA created the needed variables
for the study, after carefully assessing the demand for the
information. So instead of researchers receiving zip code
data to calculate individual distance travelled for care,
the RFA computed the distance travelled and included
it in the final dataset as a computed variable. This workaround ensured that while the researchers did not get the
zip code information, they still received the measure of
interest (distance travelled to/from facility) computed by
the RFA. A similar approach was deployed for all potential identifiable patient information. The state health
department (DHEC) and the RFA hold the keys to the
unique IDs created during the linkage. This will enable
them to apply the models and algorithms created during
the study, to individualised PLWH interventions in the
future. All data transfers occur using secure file transfer
protocols. Data are received from sources fully encrypted
and stored fully encrypted with encryption software. The
data are stored in a key-access only facility hosting servers.
Network shares for users are created via a distributed
file system and user access is controlled via user groups
containing unique IDs that require complex passwords
on facility site.
Population inclusion criteria
Only living PLWH whose residence at diagnosis was SC
are included in the study. A key question when describing
PLWH not in HIV medical care is outmigration. Census
estimates show a positive net immigration trend for SC,
and so we do not expect any problem.43 Nevertheless,
we will scrutinise the data carefully to interpret our data
appropriately in case migration becomes an issue. Only
cases with age ≥13 in the diagnosed prevalence year are
included in the analysis (ie, age must be ≥13 in 2005 to
be included in analysis). We chose 2005 since this was the
year after the state law mandatory reporting of all CD4
and VL tests to e-HARS began. Twelve years (2005–2016)
of HIV utilisation data is available for this study.

HIV medical care patterns and Gelberg-Andersen
Model variables
Gelberg-Andersen Model variables
Predisposing, enabling and need factors correspond to
the wide array of HIV data associated with linkage to care,
retention, re-engagement and ART monitoring in the
HIV treatment cascade. Variables reflecting Gelberg-Andersen Model along with their corresponding stages
along the HIV treatment cascade and their data sources
are illustrated in figure 2. Focus will be placed on categorising variables under the appropriate factor predictive
of their HIV medical care utilisation. These variables are
available from the previously described data sources.
Detailed examples of specific Gelberg-Anderson predisposing variables available through the e-HARS database
include patient name, birth date, social security number
(restricted data elements for linkage only), date of first
positive HIV test, AIDS diagnosis date, source of report
Olatosi B, et al. BMJ Open 2019;9:e027688. doi:10.1136/bmjopen-2018-027688
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Greenville Hospital System, University Medical Center,
Palmetto Health, Spartanburg Regional Healthcare
System, McLeod Health, AnMed Health and Self Regional
Healthcare and the state’s largest research-intensive
universities Clemson University, the Medical University
of SC and the University of SC. HSSC clinical data warehouse includes a Master Patient Index from multiple
health systems that allows for the matching of clinical
records across disparate information systems for a single
patient.

Open access

HIV treatment cascade
Diagnosis

Variables based on Gelberg-Andersen Model

Data sources

Level at diagnosis

Department of Health and Environmental
Control Enhanced HIV/AIDS Reporting System
(DHEC e-HARS)

►► CD4
►► Viral load

Predisposing factors
HIV linkage to care

Demographics

Revenue and Fiscal Affairs (RFA)
Medicaid
DHEC e-HARS

Health beliefs

Retention

Re-engagement

Vulnerable domains
Location

RFA
American Community Survey (ACS) Census
Tract

Criminal behaviour, violent status

Department of Corrections

Mental Illness

Department of Mental Health

Childhood characteristics

Department of Social Services (DSS)

Enabling factors
Regular source of care

Medicaid
RFA
Ryan White Service Reports (RSR)

Social support, public benefits

DSS
RSR

Health services resources

ACS Census Tract
CDC GPS data
RFA
Area Health Resource Files (AHRF)
Palmetto Health Hospital data
Greenville Health System data

Case management

DHEC e-HARS
RSR

Community resources

ACS Census Tract

Location variables (poverty, education, median
income, employment)

ACS Census Tract

Need factors
Evaluated health—diagnosis, comorbidities

RFA

Perceived health

RSR

Health behaviours

ART monitoring

Personal health practices

RFA
Health Sciences South Carolina (HSSC)
DHEC e-HARS
RSR

Use of health services
(HIV test dates, AIDS diagnosis dates)

RFA
HSSC
Palmetto Health Hospital data
Greenville Health System data
DHEC e-HARS
Continued
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Table 1 HIV treatment cascade and corresponding variables data sources*†
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HIV treatment cascade

Variables based on Gelberg-Andersen Model

Data sources

Viral suppression

Outcomes
Viral load
CD4 level

DHEC e-HARS

*All data linkage is conducted at the individual unit level using name, date of birth and social security number.
†All records from other datasets linked to the e-HARS cohort are available through the RFA and other data sources listed above.
ART, antiretroviral treatment; CDC, Centers for Disease Control and Prevention; GPS, Global Positioning System.

and transmission risk factor. Others include gender, race/
ethnicity, county of residence, year of death, cause of death
(International Classification of Diseases (ICD)-9, ICD-10
codes), poverty, education, median income, employment, and so on, all CD4 +T cell counts and VL values.
Vulnerable predisposing domain variables, such as criminal behaviour, violent status, mental illness, and childhood characteristics, are provided through RFA data
sources. Enabling factors such as regular source of care
will be obtained from Medicaid/State Healthcare plan.
Data related to social support and public benefits will be
obtained from RSR through medical case management
and RFA. Need factor variables will be obtained through
inpatient claims data from HSSC and RFA. The inpatient
data include patient demographics, source and type of
admission, visits/encounters, diagnoses, procedures,
laboratory results and length of stay. For HIV utilisation
outcomes data, e-HARS will provide CD4 and VL measures
as predictors of retention in care. The core variables for
HIV utilisation, for example, missed visits, appointment
adherence, constancy in 3-month or 4-month, 6-month
interval (retention in care variables) are described in
table 2. We will define visits/health encounters that lead
care providers to suggest HIV testing, that is, to persons
belonging to a high-risk group for HIV acquisition and
who presented with HIV-related or non-HIV-related clinical conditions.
Antiretroviral medication and polypharmacy
EHR from patient encounters available through the RFA
and HSSC capturing information about PLWH healthcare service utilisation and medications will be analysed
during the study. EHR data from the RFA contain information related to encounter visits, diagnosis, laboratory
services and medications (number prescribed, drug class,
indication, strength and dosage). Binary variables will be
created for ART status.
Data analysis plan
Data management, cleaning and mining
Data will be assessed for reliability to deal with issues
related to missing, aberrant or extreme values. New
variables and data inclusion criteria in each aim will be
validated through chart review, HIV clinicians’ expert
panel and the DTC community advisory board.26–28 We
will reduce the dimension of the variables (number
of variables) using autocorrelation, multicollinearity
6

and principal component analysis as guided. The focus
during data management will be on eliminating extreme
outliers, and excluding irrelevant variables and discretising (binning) continuous variables. Appropriate
methods will be deployed to prepare for classification and
prediction.
Population segmentation
To achieve specific aim #1, supervised and unsupervised
machine learning will be used to identify care patterns or
HIV utilisation. Once an individual is assigned to a certain
care group, it is necessary to discover a pattern that may
lead them to this care group. Thus, we will try to classify
them based on the individual and system factors that lead
the recognition of the care group. Many classification
tools are available in machine learning: logistic regression, naive Bayes classifier, support vector machine and
random forest. Most can be implemented in R. Different
distance methods (eg, Jaccard or Gower) will be deployed
to measure similarities between HIV utilisation. Once the
distance between variable is correctly measured, the clustering method, a method of unsupervised learning, will
be operated over a distance matrix instead of the original
data matrix. Both the K-means clustering and partitioning
around medoids algorithms (PAM) will be applied to
classify the data into ‘k’ groups.26–28 40 For example, we
will use cluster analysis to partition the health utilisation
data into groups of similar health utilisation behaviour.
Derived clusters will be interpretable based on relevant
Gelberg-Andersen variables and as such can be assigned a
description/class label. The result of a cluster analysis is a
binary tree, or dendrogram, with n–1 nodes. We propose
using tree pruning to adjust model complexity for the
creation of an optimal model. The simplest model with
the highest validation assessment will be considered the
best model. Statistics for judging the model will depend
on the type of prediction classifications, rankings or estimates. For prediction estimates, the squared error (difference between target and estimate) will be used to assess
model performance.2 26–28 40
Predictive modelling
For specific aims #2–3, we will identify the associations
between the missed opportunities and/or treatment
cascade, such as timing to care and consistency in care
with Gelberg-Andersen domain inputs such as gender,
race, sexual orientation, crime history, location, and so
Olatosi B, et al. BMJ Open 2019;9:e027688. doi:10.1136/bmjopen-2018-027688
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Table 1 Continued

Open access

HIV treatment cascade including Gelberg-Andersen Model variables and data sources.

on. To achieve specific aim #4, we will build and validate appropriate predictive statistical models, such as
multinomial logistic regression model, Cox proportional
hazards model and generalised linear mixed model, to
investigate the impact of care pattern, missed opportunity
and Gelberg-Andersen variables to investigate how soon
linkage to care, status in care and CD4/VL level changes.
A HIV clinician expert panel and the DTC community
group will provide guidance on the interpretation of
new findings. Once the model is validated, trained and
Olatosi B, et al. BMJ Open 2019;9:e027688. doi:10.1136/bmjopen-2018-027688

assessed using test data, it will be deployed and monitored for performance. An overview of the analytic plan
is illustrated in figure 3.
Model development and validation
Once the pattern is identified such as health utilisation
pattern, variable distributions will be summarised for
pattern status (mean, SD and counts), and compared
using the t-test, analysis of variance test and χ2 test. Where
test assumptions are not satisfied, non-parametric tests
7
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Measure
Missed visit
Appointment adherence

Type of output;
calculation overview

Observation time needed
to calculate

Dichotomous; were there any missed visits in the interval?
Count; number of missed visits in the interval
Continuous; attended appointments divided by (attended
appointments plus missed appointments)

At least 6 months
Patient: at least 1 year;
clinic: as short as 1 day

Constancy, 3-month or
4-month intervals

Categorical; number of 3-month or 4-month intervals with at least one At least 6–8 months
attended visit

Constancy, 6-month
intervals

Categorical; number of 6-month intervals with at least one attended
visit

Constancy, 6-month
intervals, longer term

Dichotomous; At least one attended visit in each 6-month interval with At least 2 years
at least 60 days between visits

Constancy, HIV/AIDS
Bureau
Gaps

Dichotomous; At least two attended visits in 12 months, separated by At least 1 year
at least 90 days
At least 1 year
Dichotomous; did the time between two contiguous attended visits
exceed a threshold (eg, 6 months)?
Continuous; what is the longest duration of time between two
contiguous attended visits?

At least 1 year

*Definitions for visits have been previously described elsewhere.25

(Wilcoxon rank test and Kruskal-Wallis Test) will be
applied. Results will be discussed among the investigation
team to find the most appropriate pattern characteristic.
Care patterns identified in aim 1 and the risk factors
and missed opportunities identified in aim 2 will serve
as the main exposure variables to identify the association
between the HIV treatment cascade, HIV care patterns
and missed opportunities. All variables in Gelberg-Andersen Behavioral Model, which can be identified in the
linked dataset, will be used as the potential risk factors.
With the patient characteristics, hospital information, care
information and variables in Gelberg-Andersen Behavioral Model, a high dimension of predictors is expected.
Cross validation will be used to evaluate the prediction
performance and to compare the different risks prediction model. The data will be divided into training, testing
and validation data. Potential interactions between

Figure 3

8

variables will be examined, using the log-likelihood ratio
test to determine statistical significance. Using machine
learning techniques, we will create algorithms that can
alert/flag high dropout risk PLWH. In addition, we will
automate the algorithms to determine the best predictors of re-engagement into HIV medical care based on
historical health utilisation patterns, CD4 counts and viral
suppression. The algorithms will be shared with DHEC
and RFA, who will apply these algorithms to the original
data. The algorithms will also be shared with the Ryan
White Program for use in monitoring and retaining
PLWH in care.
Model monitoring and validation
While the promise inherent in data mining is in discovering new and useful patterns in big data, its true value is
in responding to these patterns by acting on them. This

Analytic plan.
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Table 2 Selected variables for HIV care pattern determination*

Open access

Patient involvement
Patients were not involved in preparing this study
protocol.

Discussion
The linkage of several databases capturing traditional
clinical outcomes through the EHR and other health
claims-based system, integrated to a social determinants
of health data system under the purview of this study,
holds significant promise for HIV medical care. Prior
to this study, the confidential nature of HIV has limited
translational research across the HIV treatment cascade
to either clinical or social determinants studies, but rarely
both. The challenges with finding such data sources are
significant, as is the ability to measure variables at the
individual level. BDS techniques offer the potential of
opening new possibilities for managing complex health
conditions like HIV.43 The robust value inherent in using
population-based cohorts for improving health outcomes
and predicting future health utilisation is documented.44 45
Successful examples of previous and ongoing application
of BDS techniques can be found in automated ECG interpretation, automated detection of lung nodules from
X-rays, and creation of Framingham Risk Score.46 Other
examples using unsupervised learning for pattern identification exist in the ongoing development of precision
medicine,47–51 systolic heart failure survival prediction52
and the use of machine learning to automate diagnosis of acute brain infractions.53 BDS techniques have
Olatosi B, et al. BMJ Open 2019;9:e027688. doi:10.1136/bmjopen-2018-027688

successfully been applied to large-scale clinical studies
such as the CArdiovascular disease research using LInked
Bespoke studies and Electronic health Record study in the
UK44 and Comparison of Medical Therapy, Pacing, and
Defibrillation in Heart Failure (COMPANION) trials in
the USA.45 Studies point to these examples as the future
and real added value of BDS techniques like machine
learning.54 The combination of machine learning techniques with expert clinicians, case workers, stakeholders
together has serious potential to improve the collective
health of PLWH. This study is unique in its data linkage
and population focus, giving it strengths and precision
unavailable to previous studies using samples of PLWH
for retention in care studies. This study also goes beyond
prior studies by integrating both model development and
model validation using BDS techniques and meet the
checklists for reporting as recommended by the ‘Transparent Reporting of a multivariable prediction model
for Individual Prognosis or Diagnosis’ guidelines.55 The
novelty in this study is the integration of traditional and
vulnerable domain factors with large troves of EHR data,
and its tieback to actual linkage and retention in care.
The state department of health (DHEC) surveillance
programme, and Ryan White Program will be strengthened with the ability to flag PLWH at risk for not engaging
in care after linkage, or those at risk at dropping out of
care. This study plans to automate a process that had been
previously manually done. It also improves the process by
flagging individuals at high risk for not engaging in or
dropping out of care for intervention. In addition, locations/providers where missed opportunities for HIV care
re-engagement occurred will also receive strengthening
to improve patient engagement. DHEC’s legal mandates
allow them to work closely with clinical providers in
targeting individualised interventions to such at-risk
PLWH. This will help improve engagement in, and future
retention in care among PLWH.
Future improvement and application of the model
Plans for model improvement using future population
HIV care utilisation data will improve model performance and external validation as we focus on evaluating the incremental value of specific predictors (new
and old) for HIV care utilisation. Future data will be
deployed to the models for model maintenance and
improvement. The use of the health system by PLWH not
in care represents missed opportunities for re-engaging
them into HIV medical care. Without treatment as a
form of prevention, ending the HIV epidemic is harder
to achieve. Benefits from advances in HIV treatment are
also lost for those not in care. However, investigating
characteristics for those who are not in care is difficult
and expensive for health departments. The application
of BDS to this process will make substantive improvements, and allow clinicians, social workers and other
stakeholders help re-engage this hard to reach population back into care.
9
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ultimately moves data into information, information into
action and action into value. We anticipate developing 2–3
predictive models. After predictive models are developed,
and validated, they will be deployed against new claims
data showing healthcare utilisation. Since we have observations for PLWH who use HIV medical care consistently
(an identified segment/cluster), we will create a unique
normalised score for this population and set it as the norm
for comparison. Profiles and predictors of care status for
the not-in-care population will be assessed by the models
deployed against new claims data (2017–2018). Model
scores will be assessed to evaluate model performance
and accuracy using a propensity score analysis.2 26–28 40
Findings will be reviewed by the HIV clinician’s expert
panel as well as the DTC advisory group. They will help
inform the identification of new variables and predictors
by cross validating them based on abstracted charts. Validation rules will be established to guide this process.19
Algorithms for the model will be created and embedded
with DHEC’s HIV surveillance system and Ryan White
Program. Qualified state personnel will use this information to identify/flag those at risk for dropping out of care,
those out of care and those not likely to engage in care
after linkage. The goal in doing this is to help provide
targeted assistance to such high-risk individuals. The algorithms will be reviewed intermittently based on the availability of new data to ensure good performance.
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